Liver Disease
Conference Coverage
Novel acetaminophen hepatotoxicity strategy curbs inflammation
SAN FRANCISCO – A synthetic heparan sulfate molecule may be working in mice by interfering with neutrophil recruitment.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
Conference Coverage
U.S. death rates from chronic liver disease continue to rise
Rising mortality from chronic liver disease likely driven by an increase in obesity and type 2 diabetes.
Latest News
Norfloxacin might benefit patients with advanced cirrhosis and low ascites fluid protein levels
The mortality benefit appeared to be limited to patients with ascites fluid protein levels under 15 g/L.
From the Journals
Crohn’s disease tied to anal canal high-risk HPV infection
High-risk HPV DNA was detected in anal tissue specimens from 30% of patients with Crohn’s disease versus 18% of patients without Crohn’s disease...
Conference Coverage
Length of stay, complications predict readmission for cirrhosis patients
PHILADELPHIA – Patients with cirrhosis have a higher risk of hospital readmission if their length of stay is less...
Conference Coverage
Child-Pugh class does not affect HE recurrence in patients taking rifaximin
PHILADELPHIA – There was no significant difference in the reduction with rifaximin, compared with placebo, based on the level of hepatic...
Conference Coverage
ACIP supports hepatitis A vaccine for homeless individuals
From the Journals
Aspirin cuts risk of liver and ovarian cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
Conference Coverage
Novel score predicts esophageal varices in patients with cirrhosis prior to EGD
PHILADELPHIA – score requires no imaging to prepare, unlike current validated scores....